3Gutolo M, Bisso A, Sulli A, et al. Anfiproliferation and antiinflammatory effects of methotrexate on cultured differentiating myeloid monocytic cells (TNP-1) but not synovial macrophagesfrom rheumatoid arthritis patients. J Rheumatol, 2000, 27: 2552- 2557.
4Genestier L, PaiUot R, Fournel S, et al. Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activeated peripheral T cells. J Clin Invest, 1998, 120: 322-328.
5de Lathouder S, Gerards AH, de Groot ER, et al. Mycophenolic acid and methotrexate inhibit Iymphocyte cytokine production via different mechanisms. Eur Cytokine Netw, 2002, 13: 317-323.
6Pagano L, Mele L, Voso MT, et al. The association of topotecan and cytarabine in the treatment of relapsed acute myeloid leukearia. Haematologica, 2001, 86: 440-441.
7Estey EH. Comparison of idarubicin +Ara-C fludarabine +Ara-C and topotecan + Ara-C based regimens in treatment of newly diagnosed acute myeloid leukemia anemia with excess blasts in transformation, or refractory anemia with excess blasts. Blood, 2001, 98: 3575-3583.
8Slichenmyer WJ, Rowinsky EK, Donehower RC, et al. The current Status of Camptothecln analogues as antitumor agent. J Natl Cancer Inst, 1993, 85: 271.
9Potmesil M. Camptothecins: form bench research to hospital wards. Cancer Res, 1994, 54: 1431.
